CAS RN: 67734-35-4
(R)-tert-Butanethiosulfinate
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
95% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20260131
250mg / 1g / 5g
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 67734-35-4
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shenzhen
Inquiry
67734-35-4 / 2-tert-butylsulfinylsulfanyl-2-methylpropane
Standard CAS: 67734-35-4
Multi CAS: Yes
Basic Information
copy
CAS
67734-35-4 copy
Multi CAS
Yes copy
Molecular Formula
C8H18OS2 copy
Molecular Weight
194.400000 copy
Exact Mass
194.079908 copy
InChI
InChI=1S/C8H18OS2/c1-7(2,3)10-11(9)8(4,5)6/h1-6H3 copy
InChIKey
ZFKIFCIQBZYNIQ-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
11 copy
Fraction Csp3
1 copy
Rotatable bonds
1 copy
H-bond acceptors
2 copy
Molar refractivity
55.24 copy
TPSA
17.07 copy
LogP / Solubility
WLOGP
2.98 copy
MLOGP
2.62 copy
XLogP3
1.8 copy
Consensus LogP
2.47 copy
Log S (ESOL)
-2.86 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-3.31 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.52 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-1.79 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
2 copy